Michael Bauer
Concepts (158)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 206 | 1.470 |
Why?
| Multiple Myeloma | 20 | 2023 | 3035 | 1.470 |
Why?
| Mutation | 11 | 2021 | 1501 | 0.760 |
Why?
| Software | 6 | 2021 | 296 | 0.550 |
Why?
| Gene Expression Profiling | 6 | 2021 | 1138 | 0.530 |
Why?
| Plasma Cells | 4 | 2021 | 238 | 0.510 |
Why?
| Neoplasms | 4 | 2020 | 1316 | 0.460 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 474 | 0.450 |
Why?
| Expert Systems | 1 | 2012 | 5 | 0.440 |
Why?
| Natural Language Processing | 1 | 2012 | 38 | 0.430 |
Why?
| Information Storage and Retrieval | 1 | 2012 | 64 | 0.420 |
Why?
| Clonal Evolution | 3 | 2016 | 60 | 0.390 |
Why?
| Evolution, Molecular | 2 | 2021 | 103 | 0.380 |
Why?
| Genomics | 5 | 2022 | 310 | 0.380 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 866 | 0.290 |
Why?
| Humans | 30 | 2022 | 54284 | 0.270 |
Why?
| Proto-Oncogene Proteins B-raf | 3 | 2020 | 90 | 0.250 |
Why?
| Genome, Human | 3 | 2021 | 131 | 0.250 |
Why?
| Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 69 | 0.210 |
Why?
| Paraproteinemias | 1 | 2022 | 80 | 0.210 |
Why?
| Gene Rearrangement | 2 | 2022 | 76 | 0.210 |
Why?
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 108 | 0.200 |
Why?
| Telomere Homeostasis | 1 | 2021 | 11 | 0.200 |
Why?
| Spliceosomes | 1 | 2021 | 10 | 0.200 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2021 | 50 | 0.200 |
Why?
| RNA Splicing | 1 | 2021 | 38 | 0.190 |
Why?
| Alternative Splicing | 1 | 2021 | 64 | 0.190 |
Why?
| DNA-Binding Proteins | 2 | 2021 | 462 | 0.190 |
Why?
| Positron-Emission Tomography | 2 | 2022 | 322 | 0.190 |
Why?
| Chromosome Aberrations | 2 | 2022 | 316 | 0.190 |
Why?
| Genes, Tumor Suppressor | 2 | 2021 | 85 | 0.190 |
Why?
| Phosphoproteins | 1 | 2021 | 116 | 0.190 |
Why?
| Ecosystem | 1 | 2021 | 91 | 0.190 |
Why?
| Exosome Multienzyme Ribonuclease Complex | 1 | 2020 | 14 | 0.180 |
Why?
| Cell Cycle | 1 | 2021 | 275 | 0.180 |
Why?
| Prognosis | 6 | 2021 | 2118 | 0.180 |
Why?
| Bone Marrow | 2 | 2022 | 411 | 0.180 |
Why?
| Gene Regulatory Networks | 1 | 2020 | 124 | 0.180 |
Why?
| Epigenesis, Genetic | 2 | 2020 | 399 | 0.170 |
Why?
| Genes, myc | 1 | 2019 | 47 | 0.170 |
Why?
| Algorithms | 4 | 2020 | 697 | 0.170 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2017 | 250 | 0.170 |
Why?
| Phosphotransferases | 1 | 2018 | 24 | 0.160 |
Why?
| Oncogenes | 1 | 2018 | 63 | 0.160 |
Why?
| Mutagenesis | 1 | 2018 | 77 | 0.160 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 126 | 0.160 |
Why?
| Translocation, Genetic | 4 | 2021 | 287 | 0.160 |
Why?
| Neoplasm, Residual | 1 | 2018 | 166 | 0.160 |
Why?
| Transcription Factors | 1 | 2021 | 622 | 0.160 |
Why?
| Sequence Analysis, DNA | 2 | 2017 | 273 | 0.150 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2017 | 43 | 0.150 |
Why?
| Sequence Analysis, RNA | 2 | 2014 | 107 | 0.150 |
Why?
| Reproducibility of Results | 1 | 2021 | 1304 | 0.150 |
Why?
| Survival Rate | 4 | 2021 | 951 | 0.150 |
Why?
| Chromosome Deletion | 1 | 2017 | 150 | 0.140 |
Why?
| Disease Progression | 4 | 2021 | 913 | 0.140 |
Why?
| Flow Cytometry | 1 | 2018 | 546 | 0.140 |
Why?
| Epigenomics | 1 | 2015 | 67 | 0.130 |
Why?
| Cross-Linking Reagents | 1 | 2014 | 42 | 0.130 |
Why?
| Protein Interaction Mapping | 1 | 2014 | 44 | 0.120 |
Why?
| ras Proteins | 1 | 2014 | 70 | 0.120 |
Why?
| Lithiasis | 1 | 2014 | 1 | 0.120 |
Why?
| Clone Cells | 3 | 2021 | 89 | 0.120 |
Why?
| Bronchial Diseases | 1 | 2014 | 8 | 0.120 |
Why?
| Proto-Oncogene Proteins | 1 | 2014 | 169 | 0.120 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 573 | 0.120 |
Why?
| Cough | 1 | 2014 | 55 | 0.120 |
Why?
| Mass Spectrometry | 1 | 2014 | 313 | 0.110 |
Why?
| RNA | 1 | 2013 | 202 | 0.110 |
Why?
| Computational Biology | 2 | 2014 | 231 | 0.100 |
Why?
| Tumor Microenvironment | 2 | 2023 | 209 | 0.100 |
Why?
| Aged | 7 | 2021 | 10054 | 0.100 |
Why?
| Aged, 80 and over | 4 | 2021 | 3431 | 0.100 |
Why?
| Follow-Up Studies | 3 | 2021 | 2387 | 0.090 |
Why?
| Internet | 1 | 2012 | 275 | 0.090 |
Why?
| Databases, Factual | 1 | 2012 | 684 | 0.090 |
Why?
| Gene Dosage | 2 | 2020 | 91 | 0.090 |
Why?
| DNA, Neoplasm | 2 | 2020 | 171 | 0.080 |
Why?
| Middle Aged | 6 | 2021 | 13088 | 0.080 |
Why?
| DNA Mutational Analysis | 2 | 2020 | 217 | 0.080 |
Why?
| DNA Copy Number Variations | 2 | 2021 | 114 | 0.080 |
Why?
| Female | 8 | 2021 | 28441 | 0.080 |
Why?
| Survival Analysis | 2 | 2021 | 735 | 0.080 |
Why?
| Genomic Instability | 2 | 2018 | 95 | 0.070 |
Why?
| Neoplasm Recurrence, Local | 2 | 2022 | 644 | 0.070 |
Why?
| Transplantation, Autologous | 2 | 2018 | 476 | 0.070 |
Why?
| Bronchiectasis | 1 | 2005 | 10 | 0.060 |
Why?
| Azithromycin | 1 | 2005 | 42 | 0.060 |
Why?
| Male | 6 | 2021 | 27334 | 0.060 |
Why?
| Myeloid Progenitor Cells | 1 | 2023 | 19 | 0.060 |
Why?
| Adult | 4 | 2021 | 14207 | 0.060 |
Why?
| Signal Transduction | 2 | 2021 | 1753 | 0.050 |
Why?
| Phylogeny | 1 | 2022 | 269 | 0.050 |
Why?
| Mutation Rate | 1 | 2021 | 40 | 0.050 |
Why?
| T-Lymphocytes | 1 | 2023 | 373 | 0.050 |
Why?
| Cyclin D2 | 1 | 2020 | 20 | 0.050 |
Why?
| Aneuploidy | 1 | 2020 | 23 | 0.050 |
Why?
| Proto-Oncogene Proteins c-maf | 1 | 2020 | 20 | 0.050 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2020 | 30 | 0.050 |
Why?
| Histone Code | 1 | 2020 | 32 | 0.050 |
Why?
| Cyclin D1 | 1 | 2020 | 60 | 0.050 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2020 | 54 | 0.050 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2020 | 76 | 0.050 |
Why?
| Lymphoma, Follicular | 1 | 2020 | 30 | 0.050 |
Why?
| Alleles | 1 | 2021 | 277 | 0.050 |
Why?
| Protein Disulfide-Isomerases | 1 | 2019 | 15 | 0.040 |
Why?
| Genes, Immunoglobulin Heavy Chain | 1 | 2019 | 14 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2021 | 692 | 0.040 |
Why?
| Multivariate Analysis | 1 | 2021 | 643 | 0.040 |
Why?
| Cell Line, Tumor | 1 | 2023 | 1550 | 0.040 |
Why?
| Anti-Bacterial Agents | 1 | 2005 | 820 | 0.040 |
Why?
| Remission Induction | 1 | 2018 | 221 | 0.040 |
Why?
| Risk Factors | 2 | 2018 | 3935 | 0.040 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2019 | 278 | 0.040 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 52 | 0.040 |
Why?
| Oncogene Proteins, Fusion | 1 | 2018 | 60 | 0.040 |
Why?
| Loss of Heterozygosity | 1 | 2018 | 97 | 0.040 |
Why?
| Histones | 1 | 2020 | 335 | 0.040 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2017 | 8 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 27 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2020 | 520 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 359 | 0.040 |
Why?
| Protein-Tyrosine Kinases | 1 | 2018 | 101 | 0.040 |
Why?
| Genome-Wide Association Study | 1 | 2018 | 190 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 2017 | 87 | 0.040 |
Why?
| Fibroblast Growth Factors | 1 | 2017 | 59 | 0.040 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2017 | 169 | 0.040 |
Why?
| Genes, ras | 1 | 2016 | 48 | 0.040 |
Why?
| Treatment Outcome | 2 | 2018 | 5604 | 0.040 |
Why?
| Genes, p53 | 1 | 2016 | 60 | 0.040 |
Why?
| Amino Acid Sequence | 1 | 2018 | 767 | 0.040 |
Why?
| NF-kappa B | 1 | 2018 | 335 | 0.030 |
Why?
| DNA Methylation | 1 | 2020 | 574 | 0.030 |
Why?
| Models, Genetic | 1 | 2016 | 209 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 153 | 0.030 |
Why?
| Stem Cell Transplantation | 1 | 2016 | 196 | 0.030 |
Why?
| Succinimides | 1 | 2014 | 8 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 690 | 0.030 |
Why?
| Protein Multimerization | 1 | 2014 | 54 | 0.030 |
Why?
| Software Design | 1 | 2013 | 10 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2016 | 746 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2013 | 31 | 0.030 |
Why?
| Time Factors | 1 | 2021 | 3213 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1056 | 0.030 |
Why?
| Bronchoscopy | 1 | 2014 | 79 | 0.030 |
Why?
| Peptides | 1 | 2014 | 276 | 0.030 |
Why?
| Mice | 1 | 2023 | 6413 | 0.030 |
Why?
| Cell Proliferation | 1 | 2016 | 1096 | 0.030 |
Why?
| Transcriptome | 1 | 2013 | 346 | 0.020 |
Why?
| Chronic Disease | 1 | 2014 | 614 | 0.020 |
Why?
| Breast Neoplasms | 1 | 2020 | 1248 | 0.020 |
Why?
| Cell Line | 1 | 2013 | 1153 | 0.020 |
Why?
| Systems Biology | 1 | 2009 | 33 | 0.020 |
Why?
| Animals | 1 | 2023 | 14385 | 0.020 |
Why?
| Sputum | 1 | 2005 | 56 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2005 | 98 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2005 | 250 | 0.020 |
Why?
| Pilot Projects | 1 | 2005 | 808 | 0.010 |
Why?
|
|
Bauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|